Welcome to LookChem.com Sign In|Join Free
  • or
2(5H)-Furanone, 3-(4-fluorophenyl)-5,5-dimethyl-4-[4-(methylsulfonyl)phenyl]- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

162011-80-5

Post Buying Request

162011-80-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

162011-80-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 162011-80-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,2,0,1 and 1 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 162011-80:
(8*1)+(7*6)+(6*2)+(5*0)+(4*1)+(3*1)+(2*8)+(1*0)=85
85 % 10 = 5
So 162011-80-5 is a valid CAS Registry Number.

162011-80-5Downstream Products

162011-80-5Relevant academic research and scientific papers

Phenyl heterocycles as cox-2 inhibitors

-

, (2008/06/13)

The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. STR1 The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.

Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases

-

, (2008/06/13)

The present invention provides a method of treating a neurodegenerative disease and in particular Alzheimers disease which comprises administering to a human in need thereof a therapeutically effective amount of a non-steroid COX-II inhibitor. Although a wide range of COX-II inhibitors may be employed but it is preferred to employ compounds of the Formula I: STR1

Method of preventing bone loss

-

, (2008/06/13)

The invention encompasses a method of inhibiting bone resorption in patients in need of such inhibition to a degree sufficient to halt or retard loss of bone mass, reduce fractures, improve bone repair and prevent or treat osteoporosis comprising: the administration of a non-toxic therapeutically effective amount of a selective cyclooxygenase-2 inhibitor such as the compounds of formula I. STR1 The invention also encompasses certain pharmaceutical compositions for the purposes described above.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 162011-80-5